Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

hologic (australia & new zealand) pty ltd - ct774 - multiple-bacteria ivds - the aptima combo 2 assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection and differentiation of ribosomal rna (rrna) from chlamydia trachomatis (ct) and/or neisseria gonorrhoeae (gc) to aid in the diagnosis of chlamydial and/or gonococcal urogenital disease.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

hologic (australia & new zealand) pty ltd - ct793 - neisseria ivds - the aptima neisseria gonorrhoeae assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection of ribosomal rna (rrna) from neisseria gonorrhoeae (gc) to aid in the diagnosis of gonococcal urogenital disease

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

hologic (australia & new zealand) pty ltd - ct782 - chlamydia ivds - the aptima chlamydia trachomatis assay is a target amplification nucleic acid probe test that utilizes target capture for the in vitro qualitative detection of ribosomal rna (rrna) from chlamydia trachomatis (ct) to aid in the diagnosis of chlamydial urogenital disease.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

hologic (australia & new zealand) pty ltd - ct822 - trichomonas ivds - the aptima trichomonas vaginalis assay is an in vitro qualitative nucleic acid amplification test (naat) for the detection of ribosomal rna (rrna) from trichomonas vaginalis to aid in the diagnosis of trichomoniasis.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

hologic (australia & new zealand) pty ltd - ct946 - general laboratory reagent and consumables ivds - general laboratory reagents, products or consumables, that are intended to be used specifically as an ivd in the testing of specimens within a clinical laboratory.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

emergo asia pacific pty ltd t/a emergo australia -

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - bupivacaine hydrochloride monohydrate, quantity: 105.4 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - bupivacaine injection is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia - epidural block for surgery - field block (minor and major nerve blocks and infiltration). analgesia - continuous epidural infusion or intermittent bolus epidural administration for analgesia in post operative pain or labour pain. - field block (minor nerve block amd infiltration). the choice of 2 strengths, 0.25% and 0.5%, makes it possible to vary the degree of motor blockade.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

health sharing group pty ltd - evening primrose oil -

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

medibio ltd - 58290 - psychological assessment system application software - a software program intended to characterise cardiac autonomic, sleep, and activity patterns to aid in determining the psychological profile of a patient.

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

hologic (australia & new zealand) pty ltd -